Cost-utility analysis of Pembrolizumab compared to other alternative immunotherapy and chemotherapy treatments for patients with advanced melanoma in Iran
Article in Expert Review of Pharmacoeconomics & Outcomes Research (September 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Expert Review of Pharmacoeconomics & Outcomes Research (September 2023)
Article in Cancer Medicine (November 2022)
Article in Journal for ImmunoTherapy of Cancer (September 2022)